Clinical Trial Update: Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating unrelated umbilical cord blood transplantation using CordIn ex vivo expanded cells to accelerate engraftment in severe aplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Hypoplastic Myelodysplastic Syndrome
• Myelodysplastic Syndromes

Drugs mentioned

• CordIn

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Severe Aplastic Anemia, Hypo-Plastic MDS | Phase 1, Phase 2 | Status: RECRUITING